pharmaphorum

JANUARY 9, 2023

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. Pause in UK access. The post Free access to Zolgensma curbed, says Novartis appeared first on.

Side effects 113

Side effects Patients Management Marketing 113

European Pharmaceutical Review

NOVEMBER 15, 2022

The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. WHO Biosimilar Guideline updates.

Medicine 92

Medicine Safety Healthcare Healthcare 92

MedCity News

JUNE 1, 2023

The regulatory push for increased access Three regulations that have gone into effect in the last three years have shed light on the federal government’s push to provide patients with access to information. Access to information is one thing, but accessibility is another.

Patients 122

Patients Healthcare Healthcare Electronics 122

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. The post Prescribing shift for Pfizer’s Paxlovid expands access but draws questions appeared first on Pharmaceutical Technology.

Food and Drug Administration 111

Food and Drug Administration Physicians Prescription Medical 111

Pharmaceutical Technology

APRIL 24, 2023

In April 2019, the combination was recommended for use in the same patient population within the Cancer Drugs Fund if certain criteria outlined in the managed access program were met. GlobalData predicts an increase in disease incidence over the coming years and unequal access to treatments is a current concern.

Management 98

Management Patients 98

Pharmaceutical Technology

APRIL 27, 2023

The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. However, the reform has its share of critics.

Pharma 105

Pharma Marketing Medicine Medical 105

pharmaphorum

JULY 22, 2022

One Medical’s first-quarter results statement indicated that it was operating in 25 locations, with around 767,000 members on its books and net revenues of $254 million, more than double the same period of 2021. “We look forward to innovating and expanding access to quality healthcare services, together.”

Medical 97

Medical Healthcare Healthcare Retail 97

PM360

SEPTEMBER 21, 2023

In a July 17 statement, Maria C. “Alzheimer’s Association statement on donanemab phase 3 data reported at AAIC 2023.” Accessed August 10, 2023. “Alzheimer’s advocate testifies on access to innovative Alzheimer’s treatments.” Accessed August 10, 2023. Accessed August 10, 2023.

Manufacturing 99

Manufacturing FDA Recruitment Prospecting 99

Pharmaceutical Technology

MAY 26, 2023

The ease of the iLet, which was “designed to alleviate the work of diabetes management in everyday life and nearly eliminate the expertise that has been required to set up and manage a traditional insulin pump” as Convatec released in a statement, juxtaposes the very complex landscape of insulin at the moment.

Manufacturing 59

Manufacturing Food and Drug Administration Management Government 59

PM360

FEBRUARY 8, 2024

“The mission of Rare Patient Voice has been to empower patients and family caregivers to share their voices,” said Wes Michael, Founder and President of Rare Patient Voice, in a statement. “We This ensures our clients have access to the latest cutting-edge solutions along with a partner that is fully invested in their success.”

Media 52

Media Electronics Patients Healthcare 52

European Pharmaceutical Review

DECEMBER 19, 2022

Although the joint-statement is said to be necessary owing to the “uncertainty among stakeholders on the use of biosimilars in clinical practice”, a 2021 report by IQVIA found that the volume of biosimilar prescribing across the European Economic Area generated €5.7 What are the concerns about the interchangeability of biosimilars?

Medicine 52

Medicine Biopharma Safety Food 52

European Pharmaceutical Review

NOVEMBER 20, 2023

The trade association for Europe’s pharmaceutical industry urged in a statement that in facing the threat of AMR, a “comprehensive approach, encompassing enhanced surveillance, prudent use, preventive measures, and the development of essential antimicrobials crucial for combating antibiotic-resistant infections” is required.

Pharma 78

Pharma Pharmaceutical Manufacturing 78

Pharmaceutical Technology

OCTOBER 17, 2022

With the acquisition, Novo Nordisk will gain access to the lead development candidate of Forma, etavopivat. With the conclusion of the merger, Forma became Novo Nordisk’s fully-owned subsidiary. . The company noted that Forma’s common stock would not be listed or traded on the Nasdaq Global Select Market any longer.

Marketing 98

Marketing Patients Leads Pharmaceutical 98

European Pharmaceutical Review

AUGUST 1, 2022

ViiV Healthcare and the Medicines Patent Pool (MPP) have signed a new voluntary licensing agreement to increase access to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) in least developed, low-income, lower middle-income and Sub-Saharan African countries.

Manufacturing 85

Manufacturing Medicine Healthcare Healthcare 85

pharmaphorum

NOVEMBER 2, 2022

It has now joined Norstella’s four group companies – pharma intelligence unit Evaluate, market access specialist MMIT, healthcare data analytics software provider Panalgo and market access consultancy The Dedham Group – which were combined under the Norstella banner in May.

Pharma 75

Pharma Marketing Patients Consulting 75

pharmaphorum

SEPTEMBER 6, 2022

At a stroke, it has created a north-south divide in access to the drug, as it will not be an option for men with prostate cancer in England and Wales, but was given a green light last year for use in Scotland by the SMC, NICE’s equivalent north of the border. .

Manufacturing 109

Manufacturing Patients Marketing 109

European Pharmaceutical Review

AUGUST 1, 2022

Dubbed Disability Diversity in Clinical Trials (DDiCT), the initiative aims to provide recommendations on how to improve access, engagement, speed of enrolment and participation of people with disabilities in clinical trials.

Food and Drug Administration 111

Food and Drug Administration Medical Medicine Engineering 111

pharmaphorum

JULY 14, 2022

In a statement , the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. NICE estimates that around 2,800 people are eligible for treatment with Piqray plus fulvestrant.

Side effects 82

Side effects Medicine Patients Government 82

European Pharmaceutical Review

AUGUST 1, 2022

“Using novel technologies and the evidence generated from big data will benefit public health by accelerating medicine development, improving treatment outcomes and facilitating earlier patient access to new treatments,” said the Agency in a statement.

Medicine 93

Medicine Networking Electronics Healthcare 93

European Pharmaceutical Review

OCTOBER 1, 2022

Sharing data across borders ensures access to safe tissues and cells for human application is ethical and supply quality is adequate, said the Council in a statement.

Ethics 93

Ethics Distribution Government Safety 93

pharmaphorum

SEPTEMBER 20, 2022

The phase 1/3 ROSALIA study showed that the copycat denosumab matched Amgen’s brand on multiple pharmacokinetics, pharmacodynamics, efficacy, safety, and immunogenicity measures in postmenopausal women with osteoporosis, said Sandoz in a statement. EU rules that all biosimilars are interchangeable.

Medicine 52

Medicine Safety Marketing Biopharma 52

pharmaphorum

JANUARY 17, 2023

AstraZeneca – which is a big player in oncology and ranks among the top pharma companies for digital health investments – said in a statement that it sees its role in the partnership as providing a bridge between the NHS and technology companies like Qure.ai. ” AZ and Qure.ai

Patients 90

Patients Government Pharma Training 90

Pharmaceutical Technology

MARCH 10, 2023

The representative expected the facility to open more treatment opportunities for UK citizens saying, “It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and bring new treatments into the NHS faster.”

Manufacturing 105

Manufacturing Distribution Medicine Patients 105

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. In April 2022, BioNTech paid an upfront access fee to use Matinas’ LNC delivery platform technology. Ugur Sahin, CEO and co-founder of BioNTech, said the platform demonstrated encouraging capabilities for oral delivery, in a statement at the time.

Leads 52

Leads Pharmaceutical Patients 52

Clarity Engagement Solutions

MAY 10, 2022

Access strategy & impact statement. The key outcomes include defining an opportunity hypothesis, developing an IMPACT statement, and defining how to access decision-makers. Account-level analysis. 2. Account & opportunity prioritisation. 3. Stakeholder profiling. 4.

Training 91

Training Management Competition Medical 91

pharmaphorum

JANUARY 12, 2023

The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made access to the drugs easier. AG Steve Marshall. ” The post Women in Alabama could face prosecution over use of abortion pills appeared first on.

Pharmacology 52

Pharmacology Retail Healthcare Provider FDA 52

European Pharmaceutical Review

JANUARY 5, 2023

2022 was a pivotal year for Moderna, the company ‘s CEO noted in a recent statement. The site, called the Moderna Innovation and Technology Centre (MITC) is designed to provide access to a UK-made supply of COVID-19 vaccines. Moderna’s mRNA therapeutics strategy. At the end 2022, Moderna, Inc.

Manufacturing 59

Manufacturing Medicine Marketing Sales 59

Pharmaceutical Technology

JUNE 14, 2023

In a statement announcing the agreement, Joseph Hernandez, chairman and CEO of Blue Water, stated that the company has significantly invested in recent months with the aim of solidifying its stature as a newly transitioned commercial-stage biotech company. “We

Food and Drug Administration 52

Food and Drug Administration FDA Distribution Food 52

European Pharmaceutical Review

APRIL 28, 2023

pic.twitter.com/bjDNE4ovUM — Nathalie Moll (@NathalieMoll) April 26, 2023 Moll explained: “The vast majority of delays in access to new medicines are known to occur after a company has filed for pricing and reimbursement and is awaiting a decision, so that the new treatment can be made available to patients.”

Pharmaceutical 87

Pharmaceutical Pharma Medicine Competition 87

pharmaphorum

DECEMBER 23, 2022

Discussing provocative statements, the new Fourth Age, the hundreds of different forms of dementia, and the complexity of patients at end of life – longevity, it was clear, is a gift, but one that comes with its own challenges.

Healthcare 52

Healthcare Healthcare Patients 52

pharmaphorum

OCTOBER 12, 2022

Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research.

Retail 64

Retail Recruitment Healthcare Healthcare 64

pharmaphorum

NOVEMBER 16, 2022

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move quickly to restore access to essential services to treat the disease, as well as greater investment in new vaccines and therapeutics.

Side effects 91

Side effects Healthcare Healthcare Patients 91

pharmaphorum

OCTOBER 12, 2022

Meanwhile, patients themselves can access a range of features including remote diagnostics, virtual care and telehealth services, symptom and trigger tracking, as well as educational content and videos. The post Aptar launches digital disease management platform appeared first on.

Management 83

Management Pharma Healthcare Provider Healthcare 83

pharmaphorum

AUGUST 12, 2022

Now, DailyBreath users will be able to gain access to clinical trials that are being supported by Clariness , according to a statement from the recruitment company. Other features include reminders to take maintenance medications regularly, and tracking the effectiveness of therapies over time.

Recruitment 52

Recruitment Patients Doctors Medical 52

pharmaphorum

OCTOBER 6, 2022

Earlier this year, the CMS limited reimbursement of Aduhelm (aducanumab) to patients enrolled in clinical trials in its national coverage determination (NCD) decision for the drug – effectively ending any hope of broad access for patients and commercial viability.

FDA 52

FDA Patients Marketing Sales 52

pharmaphorum

JUNE 29, 2022

Eventually, it will also be used to improve access to screening services as well as clinical trials, and allow patients and carers to look at child health records. ” It is backed with £2 billion allocated from the spending review that will be directed at digitising medical records.

Consulting 80

Consulting Electronics Patients Recruitment 80

PM360

JUNE 6, 2023

Inizio Engage’s service offerings will be grouped into five specialist areas: Decision Optimization: Brings together expertise in data and integrated insights, treatment experience design, independent industry benchmarking, and market access.

Specialization 97

Specialization Marketing Patients Medical 97